The innovative Swiss pharmaceutical company
Kontinental Hockey League Sports Medicine Seminar KHL Leukerbad, 7th May 2010 The innovative Swis Swiss pharmaceutical company
Mepha today ■ Mepha stands for Me dicine and Pha rmacy ■ More than 6 decades of vast experience in R&D, production and sales ■ Headquarters and worldwide centre for high-tech manufacturing in Aesch near Basle, Switzerland ■ More than 100 products launched in over 50 countries ■ More than CHF 400 million annual sales. The innovative Swis Swiss pharmaceutical company
Mepha ´ s mission ■ We develop and produce attractive medical products and services in Switzerland to enable doctors and pharmacists to treat their patients with higher effectiveness and cost awareness. The innovative Swis Swiss pharmaceutical company
Mepha’s markets worldwide Mepha’s products are sold in over 50 countries worldwide Europe Switzerland Near & Middle East Lithuania Slovenia Portugal Czechia Ukraine Estonia Finland Poland Latvia Malta USA Africa Kingdom of Saudi Arabia United Arab Emirates Lebanon Bahrain Jordan Kuwait Oman Qatar America Equatorial Guinea Burkina Faso Congo Brazzaville Ivory Coast Mauritius Cameroon Tanzania Uganda Asia Nigeria Senegal Gabon Sudan Ghana Kenya Algeria Algeria Egypt Libya Niger Chad Togo Senegal Benin Mali Trinidad & Tobago El Salvador Costa Rica Guatemala Nicaragua Honduras Colombia Ecuador Panama Peru Haiti Turkmenistan Kazakhstan Hong Kong Uzbekistan Azerbaijan Singapore Malaysia Thailand Armenia Georgia Japan The innovative Swis Swiss pharmaceutical company
Mepha group sales (million CHF) Steady growth for more than a decade 450 400 350 300 250 200 150 100 50 0 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 The innovative Swis Swiss pharmaceutical company
Mepha’s product portfolio Mepharis Gasec Olfen Neurorubine Bactiflox Mesporin Tamsulosina-Mepha Simepar Mephaquin Artequin ■ With over 100 pharmaceuticals in its portfolio, Mepha offers a wide variety of products to meet the needs of patients and its broad customer base of doctors, pharmacists and distributors. The innovative Swis Swiss pharmaceutical company
Our core competencies ■ Top Swiss quality ■ Galenic innovation ■ High-tech manufacturing technologies ■ Expertise in malaria research The innovative Swis Swiss pharmaceutical company
Recommend
More recommend
